Agent | Pathway | Type of report | Effect of St. John’s wort on drug levels in the blood |
---|---|---|---|
Amitriptyline (Elavil) | CYP P450 3A4 | One-arm trial29 | Decrease |
Carbamazepine (Tegretol) | CYP 3A4 | One-arm trial30 | None |
Cyclosporine (Sandimmune) | CYP 3A4 | One-arm trial31 | Decrease |
Digoxin | CYP 3A4 | Clinical trial32 | Decrease |
Indinavir (Crixivan) | CYP 3A4 | One-arm trial33 | Decrease |
Irinotecan (Camptosar) | CYP 3A4 | Crossover trial34 | Decrease |
Midazolam (Versed) | CYP3A | Clinical trial35 | Decrease |
Nevirapine (Viramune) | CYP 3A4 | One-arm trial36 | Decrease |
Oral contraceptives | CYP 3A4 | Clinical trial35 | Decrease |
Sertraline (Zoloft) | CYP P450 3A4 | One-arm trial37 | Decrease |
Simvastatin (Zocor) | CYP 3A4 | Clinical trial38 | Decrease |
Tacrolimus (Prograf) | CYP 3A4 | One-arm trial31 | Decrease |
Theophylline | CYP 1A2 | Case report39 | Decrease |
Warfarin (Coumadin) | CYP 2C9 | Case report40 | Decrease |